Company / Operating Cash Flow
Avanos Medical, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$74.7M
FY2025
5-year range
$32.4M / $100.7M
FY2021-FY2025
Trend
-25.8%
vs FY2024
Sector context
#110 of 158
Health Care
What the data says
At $75M, Avanos Medical, Inc.'s operating cash flow ranks #110 of 158 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from -$146M in FY2018 to $189M in FY2016.
Based on SEC 10-K filings.
$75M in FY2025 with a 3-year CAGR of -6.3%.
Improved from $32M to $75M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -6.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 158 in Health CareTop 70% of 158This company $74.7M Sector average $1.0B
▼
-92.8% below sector average
Key checks
Key Insights
- 3-year CAGR of -6.3%, indicating a declining trend.
- In FY2025, operating cash flow decreased 25.8% year-over-year.
- Ranks #110 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.7M | -25.8% |
| FY2024 | $100.7M | +210.8% |
| FY2023 | $32.4M | -64.4% |
| FY2022 | $90.9M | +4.1% |
| FY2021 | $87.3M | +3592.0% |
| FY2020 | -$2.5M | +96.6% |
| FY2019 | -$74.5M | +48.8% |
| FY2018 | -$145.6M | -201.0% |
| FY2017 | $144.2M | -23.6% |
| FY2016 | $188.8M | +93.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026